Hemophilia B Patients in China Fare Worse Than Those With Type A
Hemophilia B patients living in urban mainland China have longer hospitalizations and significantly higher medical costs — including more…
Articles by Patricia Inácio, PhD
Joint Damage Seen in Hem A Patients With Milder Disease, Few Bleeds
People whose hemophilia A is mild or moderate can show marked alterations to their joints on MRI scans, particularly in the…
CSL Plasma Donates $125K to US Red Cross for Natural Disaster Relief
CSL Plasma is donating $125,000 to the American Red Cross in an effort to help lessen the burden of…
Most Severe Hemophilia Cases Tied to Mothers With No Family History, Study Finds
Well over 70% of children with severe hemophilia born in a region of Italy in the last 20 years were…
Bleeds, Physical Limits Afflict Severe Hem A Patients Despite Prophylaxis
Spontaneous and joint bleeds, and limits on physical activity are evident in people with severe hemophilia A even when they…
Unmet Medical Need in Severe Hem B Care, European Study Shows
Adults with severe hemophilia B have a persistent number of bleeds per year, as well as joint problems and…
Men Talk About Hemophilia’s Toll, Gaps in Care in Canadian Study
A hemophilia diagnosis takes a toll on the social and mental health of men, who often feel misunderstood and…
Collision Risk in Active Hemophilia A Patients Tied to Greater Bleed Risk
Physical activities with a high risk of a collision are linked with a greater risk of bleeding in people with moderately…
HOPE-B Trial Update: Gene Therapy Candidate AMT-061 Meeting Goals
After 18 months, the investigational gene therapy AMT-061 (etranacogene dezaparvovec) continued to prevent bleeds in men with moderate-to-severe…
BioMatrix Announces Winners of Its 2021 Memorial Scholarship Program
BioMatrix Specialty Pharmacy has announced this year’s winners of its memorial scholarship program, designed to help people with…